·
6 Min Read

April 24, 2020: State Advocacy Update

In the latest Advoaccy Update, the AMA called on governors to adopt civil immunity for physicians providing COVID-19-related care.

Advocacy Update
·
10 Min Read

April 17, 2020: National Advocacy Update

Advocacy spotlights new cyber treats during COVID-19 and physician protections as well as new policies for opioid treatment programs.

Advocacy Update
·
6 Min Read

April 17, 2020: State Advocacy Update

Policy options for states to address COVID-19 and more State Advocacy Update news.

Advocacy Update
Man wearing a face mask
·
3 Min Read

New policies on treating pain, OUD emerge from COVID-19 crisis

The DEA is allowing qualified physicians to prescribe buprenorphine over the telephone so patients can stay home. The AMA urges states to do the same.

Behavioral Health
·
1 Min Read

AMA urges governors to adopt DEA guidance for opioid use disorder

This guidance removes a considerable barrier for many patients during the COVID-19 national emergency and, importantly, allows them to stay at home.

Press Releases
Patient speaking with physician
·
4 Min Read

New York effort raises use of MAT for opioid-use disorder

Medications for addiction treatment (MAT) are underused, with racial, geographic and economic barriers. Learn about a Big Apple initiative that’s making big changes.

Behavioral Health
·
3 Min Read

After his son’s death, Massachusetts physician seeks to help others

James Baker, MD, whose son died of an overdose at 23, provides phone support to primary care doctors treating patients with substance-use disorders.

Behavioral Health
·
5 Min Read

Feb. 28, 2020: State Advocacy Update

Warning on naloxone in CO, prior authorization in ME and more in AMA's latest state advocacy efforts.

Advocacy Update
·
3 Min Read

Removing prior authorization for MAT results in more patient care

Learn how Maryland has changed the law to help patients with opioid-use disorder get the evidence-based care they need.

Prior Authorization